Biogen Idec (NASDAQ:BIIB)

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

4 Large Cap Biotech Leaders Are Huge Tax Reform Winners

With the U.S. House and the Senate now working together to patch up differences between the two tax reform bills, one thing looks pretty certain: In one shape or another, ...
Read Full Story »

2018 Outlook: Biotech Stocks Looking Strong for Value and Growth Investors

With 2017 coming to an end, investors are wondering how they should be investing for 2018 and beyond. At the start of December, the Dow was up just over 20% ...
Read Full Story »

Alkermes Could Win Big With New Biogen Partnership

Alkermes PLC (NASDAQ: ALKS) shares made a handy gain to start the week, after the firm announced that it has entered into a global license agreement with Biogen Inc. (NASDAQ: ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

During the presidential campaign of 2015–2016, one of the areas that got some of the largest scrutiny was drug pricing, and with good reason. Spending on pharmaceuticals when the population ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix.com and More

After a week of stocks seeming to look for a direction, while still bumping up against all-time highs, the major stock indexes were all indicated handily lower on Thursday morning. ...
Read Full Story »

Short Sellers Chase Biotechs Higher

The short interest data are out for the most recent settlement date, October 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Apple, Biogen, Capital One, Chipotle, GM, 3M and More

Stocks have hit new high after new high, but Wednesday's opening indication was looking marginally lower on all three major U.S. stock indexes. The trend that has prevailed for more ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Equifax, Foot Locker, GE, NVIDIA, Rio Tinto, Roku and More

Stocks have hit new highs and the Dow Jones Industrial Average went well above 23,000 by 300 points last week. Stocks were also indicated to open higher on Monday. The ...
Read Full Story »

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Third-quarter earnings reporting season is now well under way. So far, things are looking good. The health care sector has yet to see any significant earnings representation, but that will ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Biogen, Carbonite, Celgene, Emerson Electric, Kinder Morgan, Netflix, UnitedHealth and Many More

Stocks hit a new high on Monday, and they were indicated to open slightly higher on Tuesday. The Dow is now knocking on 23,000's door, and this bull market is ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, September 29. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's ...
Read Full Story »